BOSTON SCIENTIFIC CORP
BSXHealthcarebostonscientific.com
Latest available resultsSeptember 30, 2026Quarter · 10-Q filed Nov 2, 2026
Next reportFebruary 2, 2027after close · forecast 0.784 $/share
Revenue
$5.14B
▲ +1.4% vs prior year YoY
Net income
$580.00M
▼ -23.2% vs prior year YoY
EPS
0.40$
▼ -21.6% vs prior year YoY
Net margin
11.3%
▼ -3.6 pp vs prior year YoY
Revenue▲ +1.4%
Margins (% of revenue)GrossOperatingNet
Net income▼ -23.2%
EPS▼ -21.6%
Financial statements
View 10-Q filed November 2, 2026 on SEC ↗| Metric | Dec 2024* | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025* | Mar 2026 | Jun 2026 | Sep 2026 | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Operations | |||||||||
| Revenue | $4.56B | $4.66B | $5.06B | $5.07B | $5.29B | $5.20B | $5.44B | $5.14B | ▲ +1.4% |
| Gross profit | $3.10B | $3.21B | $3.42B | $3.54B | $3.68B | $3.61B | $3.85B | $3.43B | ▼ -3.2% |
| Operating income | $675.00M | $921.00M | $819.00M | $1.05B | $825.00M | $1.10B | $1.18B | $828.00M | ▼ -21.0% |
| Net income | $563.00M | $672.00M | $795.00M | $755.00M | $670.00M | $1.34B | $905.00M | $580.00M | ▼ -23.2% |
| R&Dnever filed | — | — | — | — | — | — | — | — | — |
| EPS (diluted) | — | 0.45 $ | 0.53 $ | 0.51 $ | — | 0.90 $ | 0.61 $ | 0.40 $ | ▼ -21.6% |
| Margins (% of revenue) | |||||||||
| Gross | 67.8 % | 68.8 % | 67.7 % | 69.9 % | 69.6 % | 69.5 % | 70.7 % | 66.7 % | ▼ -3.2 pt |
| Operating | 14.8 % | 19.8 % | 16.2 % | 20.7 % | 15.6 % | 21.2 % | 21.6 % | 16.1 % | ▼ -4.6 pt |
| Net | 12.3 % | 14.4 % | 15.7 % | 14.9 % | 12.7 % | 25.7 % | 16.6 % | 11.3 % | ▼ -3.6 pt |
| Balance sheet | |||||||||
| Assets | $39.40B | $40.14B | $41.56B | $42.71B | $43.67B | $44.35B | $45.22B | $45.46B | ▲ +6.4% |
| Liabilities | $17.39B | $17.69B | $18.91B | $19.08B | $19.20B | $18.25B | $20.04B | $19.59B | ▲ +2.7% |
| Equity | $22.00B | $22.45B | $22.65B | $23.63B | $24.47B | $26.10B | $25.17B | $25.87B | ▲ +9.5% |
| Cash | $414.00M | $725.00M | $534.00M | $1.27B | $1.97B | $1.45B | $539.00M | $609.00M | ▼ -52.2% |
| Capital | |||||||||
| Shares outstanding | 1.48B | 1.48B | 1.48B | 1.48B | 1.48B | 1.49B | 1.45B | 1.45B | ▼ -2.2% |
| Public floatexcluding insiders | — | — | — | — | — | — | — | — | — |
* No 10-Q is filed for a fourth quarter: these amounts are the fiscal year minus the first three quarters, all filed. EPS stays blank — dilution doesn't subtract.